AbbVie (ABBV)
$173.15
0.46 (0.26%)
ABBV Stock Quote Delayed 30 Minutes
Are These 10 High-Yielding S&P Dividend Stocks Traps or Treasures?
Like 2018, the market looks like it may be setting up for another rocky Q4. Here's your guide on which defensive high-yield stocks to buy, and which to avoid.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
2.93M
Day's Range
$172.77 - $174.59
52-Week Range
$135.85 - $182.89
Dividend & Yield
$5.92 (3.42%)
ABBV Stock Predictions, Articles, and AbbVie News
Stock Market Today: How Many Times Will the Fed Cut Rates?
After six straight sessions of losses, it was a welcomed sight to see stocks rally on Tuesday. Here's what happened on the stock market today.
AbbVie Earnings: ABBV Stock Pops on Q2 Beat
AbbVie earnings for the second quarter of 2019 have ABBV stock up on Friday thanks to it beating EPS and revenue estimates.
Why Bristol-Myers Squibb Stock Is Stumbling Ahead of Earnings
Investors turned sour on BMY stock after the Celgene buyout. Will a solid Q2 earnings report change the sentiment for the better?
This Pharmaceutical Company is Oversold and Starting to Recover
This morning, I am recommending a bullish trade on AbbVie, Inc. (NYSE:ABBV), the biopharmaceutical company.
Wednesday’s Vital Data: AbbVie, FedEx and Micron
Options trading was buzzing in AbbVie, FedEx and Micron Tuesday. Here are the metrics that matter moving forward.
3 Big Stock Charts for Wednesday: Tyson Foods, Lennar and State Street
The stock charts of TSN, STT and LEN are headed into the midpoint of the week on the verge of major turns.
5 Top Stock Trades for Wednesday — AGN, ABBV, FDX, MSFT, BB
AbbVie is buying Allergan, FedEx and Blackberry are reporting earnings and Microsoft is on the move. Here are our top stock trades.
AbbVie-Allergan Deal: AGN Stock Soars on $63 Billion Buyout
News of an AbbVie-Allergan deal has AGG stock heading higher on Tuesday with plans for the former company to acquire the latter.
3 Big Stock Charts for Monday: Medtronic, Paychex and AbbVie
The stock charts of Medtronic, Paychex and AbbVie are poised to get the new trading week started with a bang.
10 Smart Dividend Stocks for the Rest of the Year
Ford, Verizon and AbbVie are just a trio of the top dividend stocks to buy for the remainder of 2019, particularly if the broad market hits turbulence.
Two Healthcare Stocks in the XLV Fund Stand Out
MRK stock and ABBV stock are promising healthcare stocks to invest in from the XLV fund. MRK is 6% of holdings and AbbVie makes up 3.5%.
Profit from Earnings Volatility With This Biotech Stocks Pairs Trade
Play a friendly and widening price spread in biotech stocks with a well-place purchase in Merck and an equally smart short in AbbVie.
3 Big Stock Charts for Friday: AbbVie, ConocoPhillips and MGM Resorts
The stock charts of COP, MGM and ABBV stock are moving into pivotal positions as the trading week winds down.
